Acetylcysteine: all 450 studies that test it

Page 3 of 5. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled TrialStatus unknownNCT05738681Phase 2/3
• Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19Status unknownNCT05736887Phase 2
• A Pan-TB Regimen Targeting Host and MicrobeActive, not recruitingNCT05686356Phase 2/3
• Effect of N-acetylcysteine Versus Calcium Hydroxide Used as an Intracanal Medicament on the Intensity of Postoperative Pain, Bacterial Load Reduction and Levels of MMP -9 in Periapical Fluids in Patients With Necrotic PulpStatus unknownNCT05666089Early Phase 1
• Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 PatientsCompletedNCT05658549Phase 1/2
• N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric LeukemiaTerminatedNCT05611086Phase 4
• Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)CompletedNCT05610072Early Phase 1
• Assessment of the Impact of N-acetylcysteine Supplementation on Physical PerformanceCompletedNCT05604586Not applicable
• Oral N-acetylcysteine for Retinitis PigmentosaActive, not recruitingNCT05537220Phase 3
• the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant EpilepsyCompletedNCT05485558Phase 2
• NAC Effect on Infertile Women With EndometriomaStatus unknownNCT05460858Phase 3
• The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19WithdrawnNCT05371288Early Phase 1
• The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth SyndromeCompletedNCT05309070Not applicable
• Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)CompletedNCT05294744Not applicable
• Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic StimuliCompletedNCT05287724Early Phase 1
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory DiseaseStatus unknownNCT05258682Phase 1/2
• Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy ParticipantsCompletedNCT05242718Not applicable
• Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple SclerosisActive, not recruitingNCT05122559Phase 2
• Intravenous NAC Use in ACLF PatientsStatus unknownNCT05089981Not applicable
• A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for LymphomaActive, not recruitingNCT05081479Phase 1
• Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common ColdWithdrawnNCT05070650Phase 3
• Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma PeritoneiStatus unknownNCT04982146Phase 1
• A Study of NAC for AUDWithdrawnNCT04964843Phase 2
• Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19Status unknownNCT04928495Phase 3
• N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKETerminatedNCT04920448Phase 2
• Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic StrokeCompletedNCT04918719Phase 2
• N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney DiseaseCompletedNCT04916080Phase 2
• Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD PatientsStatus unknownNCT04904952Not applicable
• N-acetylcysteine for Primary Sjögren's SyndromeCompletedNCT04793646Not applicable
• Effect of N-acetylcysteine on Oxidative Stress in COVID-19 PatientsCompletedNCT04792021Phase 3
• Effect of High-Dose NAC on Patients With DPNStatus unknownNCT04766450Phase 4
• The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol ChromoendoscopyCompletedNCT04764643Not applicable
• N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.Status unknownNCT04756622Phase 3
• Glutathione, Brain Metabolism and Inflammation in Alzheimer's DiseaseActive, not recruitingNCT04740580Early Phase 1
• Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell TransplantationStatus unknownNCT04712435Phase 2
• Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19TerminatedNCT04703036Early Phase 1
• Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue SyndromeActive, not recruitingNCT04542161Phase 2
• Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced NephropathyStatus unknownNCT04531163Phase 2/3
• NAC Supplementation and Soccer Specific PerformanceCompletedNCT04523675Not applicable
• Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide PoisoningStatus unknownNCT04509258Phase 4
• Inflammatory Regulation Effect of NAC on COVID-19 TreatmentStatus unknownNCT04455243Phase 3
• Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe DiseaseCompletedNCT04419025Phase 2
• The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal SymptomsCompletedNCT04405193Phase 2/3
• A Study of N-acetylcysteine in Patients With COVID-19 InfectionActive, not recruitingNCT04374461Phase 2
• The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITPStatus unknownNCT04368598Phase 2
• Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) TrialCompletedNCT04300920Phase 3
• Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.Status unknownNCT04291209Phase 1/2
• The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia MajorCompletedNCT04260516Phase 1
• Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced OtotoxicityTerminatedNCT04226456Phase 4
• N-Acetylcysteine Protection Against Radiation Induced Cellular DamageCompletedNCT04154982Phase 2
• N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension.Status unknownNCT04081012Not applicable
• A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMICompletedNCT04023266Phase 2
• Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on HomocystinuriaSuspendedNCT04015557Phase 1/2
• Effect of N-Acetyl Cysteine (NAC) on the Oral MicrobiomeWithdrawnNCT03982537Phase 2
• BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma PeritoneiStatus unknownNCT03976973Phase 2
• Risk Stratification-directed NAC for Prevention of Poor Hematopoietic ReconstitutionStatus unknownNCT03967665Phase 3
• The Anti-oxidant Effects of N-Acetylcysteine in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03956888Phase 3
• N-acetyl-cysteine and Carbohydrate Metabolism Disorder in Obese WomenStatus unknownNCT03902327Not applicable
• The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol DependenceStatus unknownNCT03879759Phase 2
• Supportive Measures in Treatment of Aluminum Phosphide PoisoningCompletedNCT03879356Phase 4
• NAC Effect on Hox Genes Expressions in RIFCompletedNCT03862586Phase 3
• N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO TrialCompletedNCT03759158Not applicable
• Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery CatheterizationStatus unknownNCT03755700Phase 3
• Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar DepressionCompletedNCT03730064Early Phase 1
• Redox Regulation of Satellite Cells and Skeletal Muscle HealingCompletedNCT03711838Not applicable
• Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) PancreatitisStatus unknownNCT03708458Phase 4
• Adjunctive NAC in Adult Patients With Pulmonary TuberculosisCompletedNCT03702738Phase 2
• Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol OverdoseCompletedNCT03679442Phase 1
• RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteineCompletedNCT03636932Phase 2
• Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP)TerminatedNCT03596125Phase 2/3
• Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon SurgeriesCompletedNCT03589495Phase 4
• Clinical Trial of Antioxidant Therapy in Patients With Septic ShockStatus unknownNCT03557229Phase 3
• Evaluation of N-Acetylcysteine Efficacy to Reduce the Craving and to Prolong Abstinence Time of Coca PasteCompletedNCT03556371Phase 2
• NAC Prevents Toxicity of Teeth BleachingCompletedNCT03534115Early Phase 1
• Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.CompletedNCT03510741Phase 2
• Glutathione in Mild Cognitive ImpairmentActive, not recruitingNCT03493178Early Phase 1
• N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer PatientsCompletedNCT03492047Phase 1/2
• The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03460808Phase 1/2
• N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic RevascularizationTerminatedNCT03451435Early Phase 1
• Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve ReplacementStatus unknownNCT03440268Phase 4
• Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients with Cocaine AddictionTerminatedNCT03423667Phase 2
• Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck CancerCompletedNCT03400709Not applicable
• Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive TherapyTerminatedNCT03391856Phase 2/3
• Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD.CompletedNCT03388853Phase 4
• Nebulized N-Acetyl Cysteine for Bronchiolitis in Inpatient Hospital UseStatus unknownNCT03364218Phase 4
• Pilot Study: Postoperative Pain Reduction by Pre Emptive N-AcetylcysteineCompletedNCT03354572Phase 4
• N-Acetyl-cysteine in Early Acute Respiratory Distress SyndromeWithdrawnNCT03346681Early Phase 1
• Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell TransplantationCompletedNCT03236220Phase 2
• N-acetylcysteine for the Treatment of Cannabis Dependence: Working MechanismsStatus unknownNCT03221231Phase 4
• The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry CorrectionStatus unknownNCT03197103Phase 4
• N-Acetylcysteine and L-carnitine in PcosCompletedNCT03164421Phase 2
• Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis UsersCompletedNCT03154580Phase 1
• "Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"TerminatedNCT03149107Phase 3
• The Effects of N-acetylcysteine on Performance and Redox HomeostasisCompletedNCT03121222Phase 2
• Topiramate Augmenting Strategies for the Treatment of Alcohol Use DisorderCompletedNCT03120468Early Phase 1
• Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption ProtocolTerminatedNCT03104959Not applicable
• The FIGHT-RP1 StudyCompletedNCT03063021Phase 1
• Antioxidant Use in Diabetes to Reduce Oxidative StressTerminatedNCT03056014Early Phase 1
• Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.Status unknownNCT03018236Phase 4
• Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?Status unknownNCT03014882Phase 1/2

← Acetylcysteine overview